Editas Medicine, Inc.
EDIT
$2.82
$0.010.36%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 11.89M | 2.83M | 24.74M | 7.54M | 3.58M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 11.89M | 2.83M | 24.74M | 7.54M | 3.58M |
| Cost of Revenue | 20.18M | 17.60M | 27.40M | 19.78M | 16.18M |
| Gross Profit | -8.29M | -14.77M | -2.66M | -12.23M | -12.60M |
| SG&A Expenses | 11.60M | 10.23M | 11.35M | 12.32M | 12.86M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 31.78M | 27.83M | 38.76M | 32.09M | 29.04M |
| Operating Income | -19.89M | -25.00M | -14.02M | -24.55M | -25.46M |
| Income Before Tax | -18.23M | -24.98M | -5.62M | -25.12M | -53.24M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -18.23M | -24.98M | -5.62M | -25.12M | -53.24M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -18.23M | -24.98M | -5.62M | -25.12M | -53.24M |
| EBIT | -19.89M | -25.00M | -14.02M | -24.55M | -25.46M |
| EBITDA | -19.48M | -24.52M | -13.21M | -23.83M | -23.63M |
| EPS Basic | -0.15 | -0.26 | -0.06 | -0.28 | -0.63 |
| Normalized Basic EPS | -0.10 | -0.16 | -0.06 | -0.17 | -0.20 |
| EPS Diluted | -0.15 | -0.26 | -0.06 | -0.28 | -0.63 |
| Normalized Diluted EPS | -0.10 | -0.16 | -0.06 | -0.17 | -0.20 |
| Average Basic Shares Outstanding | 119.29M | 97.88M | 97.26M | 90.09M | 84.41M |
| Average Diluted Shares Outstanding | 119.29M | 97.88M | 97.26M | 90.09M | 84.41M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |